The TIMI Risk Score for Unstable Angina/Non–ST Elevation MIMyeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI ...The year in non-ST-segment elevation acute coronary syndromeThe year in non-ST-segment elevation acute coronary syndromeThe year in acute coronary syndromeThe path to an angiotensin receptor antagonist-neprilysin inhibitor in the treatment of heart failureApplication of current guidelines to the management of unstable angina and non-ST-elevation myocardial infarctionImplications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trialCorrelation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation acute coronary syndromes: observations from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and SyRandomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trialComparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofibanThe A-to-Z Trial: Methods and rationale for a single trial investigating combined use of low-molecular-weight heparin with the glycoprotein IIb/IIIa inhibitor tirofiban and defining the efficacy of early aggressive simvastatin therapyEffect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY studyAn integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUSBivalirudin as a replacement for unfractionated heparin in unstable angina/non-ST-elevation myocardial infarction: observations from the TIMI 8 trial. The Thrombolysis in Myocardial InfarctionAngiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 TrialProspective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non-ST-elevation acute coronary syndromesBenefit of an early invasive management strategy in women with acute coronary syndromesDirect comparison of characteristics, treatment, and outcomes of patients enrolled versus patients not enrolled in a clinical trial at centers participating in the TIMI 9 Trial and TIMI 9 RegistryPrior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-ThromSafety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trialEvaluation of the National Cholesterol Education Program Adult Treatment Panel III algorithm for selecting candidates for statin therapy: insights from the A to Z trialEvaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In MyocardialDrug-induced thrombocytopenia and thrombosis: evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the Orbofiban in Patients with Unstable coronary Syndromes- (OPUS-TIMI 16) trialAssociation between platelet receptor occupancy after eptifibatide (integrilin) therapy and patency, myocardial perfusion, and ST-segment resolution among patients with ST-segment-elevation myocardial infarction: an INTEGRITI (Integrilin and TenecteUnstable angina and non-ST-segment elevation myocardial infarction: part I. Initial evaluation and management, and hospital careUnstable angina and non-ST-segment elevation myocardial infarction: part II. Coronary revascularization, hospital discharge, and post-hospital careEfficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrelEnoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trialRecombinant nematode anticoagulant protein c2 in patients with non-ST-segment elevation acute coronary syndrome: the ANTHEM-TIMI-32 trialAddition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevationRole of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trialGenetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trialsTenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trialBiomarkers in heart failureSaxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitusA Sensitive Cardiac Troponin T Assay in Stable Coronary Artery DiseaseThe evolving epidemiology of acute coronary syndromes.Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group.Bariatric surgery: a systematic review and meta-analysis.
P50
Q22252998-56541F92-8E53-444E-9907-211A579E442DQ24650933-E9829273-E527-40B5-A2B0-0E7929B47195Q26823317-3C15CBFA-A98B-4EDB-B95D-781CAE6BF31DQ26829746-93AEC752-BB5A-41F3-82C2-13377416D0D5Q27010643-BB4E6C6C-32BB-40A6-A6C6-5FD34024C5DDQ28084755-E868E8B9-92E6-4158-AC7C-BE23A939D57FQ28166001-48BB210E-6970-4972-8578-047488C294EBQ28167073-350082A9-AC80-4CC5-9976-3D11B2381087Q28175521-5F3A90DF-F7BF-42A6-A24D-60807B651D63Q28181168-890FBC5C-3B35-488B-80C4-F8C05657C2AFQ28185502-FDE7D020-67F6-457E-9DC1-8D81D0B2BD76Q28187087-FBBD27EC-FABC-41F8-9602-47BEA6E67481Q28190808-69BB7971-51C3-4424-B981-6E9B6AE94517Q28192108-00253482-2DEB-4D1F-B3DF-E32853E94746Q28192335-E5315624-C481-4D51-B2F6-BD091942E292Q28193401-E9DA3D44-486D-43D6-A85B-D3AE6B782A7FQ28193852-5A5AB98B-A90C-4683-A8CF-10B074FF6503Q28194492-E4D8F5D3-D461-487C-B83F-8F8F2054F11EQ28194572-BD05F9B1-D64E-44A6-8944-8E8BB47796C7Q28195611-2F17C251-AC10-4D70-A28D-BDEBFAE05645Q28198865-DB6723CC-329E-4A74-85B3-BECC97526CF0Q28200409-5F7295A5-0946-41FA-A889-3F830307B7A7Q28200530-870F5586-B7E9-44A4-A358-98C9C1B59859Q28200573-13FE9146-913A-4067-A3BA-ADA990E3505BQ28209164-0407D91A-AD03-433B-B935-C0731975DD31Q28211184-337120B6-BDB8-40B5-AD5D-5C3C9B8FF7E5Q28211194-C04E286A-67CD-4519-9CE1-DDDF386AE1A8Q28212984-1A1B3555-5A10-4164-B640-819329EDD346Q28213887-57CC1D1D-34DE-4EA0-AC46-562B88C8F86FQ28217795-2326A81F-2E32-4ED2-A7C3-C63EC9AAD3FDQ28218789-A9A8F875-C491-4DAA-943A-4260C5009057Q28253329-2C465D81-AD7D-4E27-9E35-F2B081FB163DQ28258442-AD52A02C-C352-4D93-8C6A-186E5675C61AQ28266097-EF2AEF5E-19DB-4EC1-98C6-63C07827A503Q28280109-F7F711BF-45EB-4A03-8B3B-6C9BDF0EFB13Q28297680-9ABBCD88-05AE-4348-AE0C-623FA0D5FE75Q29028464-E9D96487-3457-4B04-8ADE-C2D02C648C30Q30397739-D5CF203D-5B47-4F9A-8B17-A351174AFAEDQ30596519-CD05E1FF-893C-481E-A399-82891A0F0852Q30769299-5247335D-5FB7-484D-8F9C-A79F2B7CB1F5
P50
subject
description
American cardiologist
@en
Amerikaans cardioloog
@nl
US-amerikanischer Kardiologe
@de
amerikansk kardiolog
@da
amerykański kardiolog
@pl
cardiolojiste american
@lfn
cardiólogu estauxunidense
@ast
medico austriaco
@it
usona kardiologo
@eo
طبيب قلب من الولايات المتحدة الأمريكية
@ar
name
Eugene Braunwald
@ast
Eugene Braunwald
@ca
Eugene Braunwald
@cy
Eugene Braunwald
@da
Eugene Braunwald
@de
Eugene Braunwald
@en
Eugene Braunwald
@es
Eugene Braunwald
@eu
Eugene Braunwald
@fi
Eugene Braunwald
@fo
type
label
Eugene Braunwald
@ast
Eugene Braunwald
@ca
Eugene Braunwald
@cy
Eugene Braunwald
@da
Eugene Braunwald
@de
Eugene Braunwald
@en
Eugene Braunwald
@es
Eugene Braunwald
@eu
Eugene Braunwald
@fi
Eugene Braunwald
@fo
altLabel
Eugène Braunwald
@fr
Євген Браунвальд
@uk
prefLabel
Eugene Braunwald
@ast
Eugene Braunwald
@ca
Eugene Braunwald
@cy
Eugene Braunwald
@da
Eugene Braunwald
@de
Eugene Braunwald
@en
Eugene Braunwald
@es
Eugene Braunwald
@eu
Eugene Braunwald
@fi
Eugene Braunwald
@fo